Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here. 		You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
BLOG
EVENT CALENDAR
COLUMNS
WHITE PAPERS
THE MAGAZINE
  Pharmaceutical Technology Europe E-Alert
 
23 September 2011

IN THIS ISSUE
• Race cars and GSK
• US deficit plan
• Irish investments
• Cash for cancer
 
GSK to harness Formula 1 technology
GlaxoSmithKline (GSK) is looking to race car technology as it seeks to improve its manufacturing, R&D and consumer-healthcare areas. The company has formed a long-term partnership with the UK-based McLaren Group, which is best known for its expertise in the Formula 1 motor sport. More...
 
Obama to ban "pay-to-delay"
President Obama’s deficit plan includes several potentially painful provisions for pharma, including a ban on pay-to-delay strategies and evergreening, and a reduction of the exclusivity period for biologics. More...
 
Pfizer and Alkermes to boost Irish manufacturing
Ireland has received a double dose of fortune from pharma; in separate deals, Pfizer will invest in its Grange Castle manufacturing facilities, and Alkermes will begin a multiyear, multimillion manufacturing supply agreement. More...
 
GE Healthcare to invest $1 billion in Oncology
GE Healthcare intends to dedicate $1 billion of its total R&D budget during the next five years to its technologies for biopharmaceuticals and cancer research. More...
 
Novartis updates on strategies and achievements
Novartis has presented an update on its long-term strategy, performance and growth outlook, and highlighted some of its main achievements in the last 18 months, such as its double-digit sales growth, which has been attributed to new products and the integration of eye-care company Alcon. More...
 
Join our community on LinkedIn
Want to discuss any of this week's news stories or any other hot topics in the industry? Then why not join our group on LinkedIn? More...
 

Latest blog posts
PDA-FDA: summary of supply chain compliance update
Changing times for pharma chemical outsourcing
A call of clarity about vaccines
More blog posts

Latest articles
The EU Debt Crisis and CMOs
API purification
Health Technology Assessment
More articles

Upcoming events
TechnoPharm (11–13 October | Germany)
World Innovation Congress (18–20 October | UK)
BioProduction 2011 (19–20 October | Germany)
More events

Product/Service Profiles
Flexicon Liquid Filling

FF30 Aseptic Filling and Capping Machine
The new Flexicon FF30 aseptic filling and capping machine delivers a consistent level of production quality which is impossible to maintain with manual assembly of bottles and caps. Read more
 
Intertek

Reviewing your 2012 analysis outsourcing plans?
Whether your needs cover GLP/ GCP Bioanalysis, GMP Biopharma and Pharma analysis, GMP Auditing, Method development and Validation or GMP Microbiology book a meeting with the Intertek Team (41D57) at ICSE / CPhi.
Read more

 
Shimadzu

The Nexera MP UHPLC for LC/MS analysis in drug detection processes
Shimadzu has introduced the Nexera MP UHPLC as a Front End system for LC/MS. The Nexera MP is perfect for LC/MS analysis conducted in pharmacokinetics and synthesis stages in drug detection processes. Read more

 
Sterilin

High quality pharmaceutical packaging products
Sterilin high quality plastic packaging products are ideal for storing and transporting a wide range of pharmaceutical products. Read more
 
 
Survey
Is quality by design changing the expectations between sponsor companies and contract service providers when outsourcing API development and manufacturing?
■ Yes 83%
 
■ No 17%

This week we would like to know...

FDA released its new enforcement strategy in August 2010. Has your company experienced FDA increased scrutiny in the past year?

Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing [email protected] or by mail at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK.